Pharmabiz

XELIX unveils India’s first curated network of certified dermatologists and aesthetic experts at FAHA Medical Conference

XELIX unveils India’s first curated network of certified dermatologists and aesthetic experts at FAHA Medical Conference: Our Bureau, Mumbai Wednesday, July 29, 2026, 17:30 Hrs ...
Pharmabiz

Nova IVF opens advanced embryology lab in Lullanagar, Pune

Our Bureau, Mumbai Wednesday, July 29, 2026, 15:15 Hrs [IST] Nova IVF Fertility, Lullanagar, Pune, has launched an embr ...
Pharmabiz

ProMIS Neurosciences announces positive blinded six-month interim safety and biomarker data for PMN310 in the PRECISE-AD phase 1b Alzheimer’s disease trial

ProMIS Neurosciences announces positive blinded six-month interim safety and biomarker data for PMN310 in the PRECISE-AD phase 1b Alzheimer’s disease trial: Cambridge, Massachus ...
Pharmabiz

Akeso begins patient dosing in phase Ib/II study of HER3 ADC (AK138D1) combined with ivonescimab in lung cancer

Akeso begins patient dosing in phase Ib/II study of HER3 ADC (AK138D1) combined with ivonescimab in lung cancer: Hong Kong Wednesday, July 29, 2026, 18:00 Hrs [IST] Akeso, Inc., a ...
Pharmabiz

Dabur Q1 net profit surges 15% at Rs. 591 crore

Our Bureau, Mumbai Wednesday, July 29, 2026, 17:20 Hrs [IST] India's leading science-based Ayurveda major Dabur India Limited anno ...
Pharmabiz

Parexel recognized as a World’s Top Disability Inclusive Business

Parexel recognized as a World’s Top Disability Inclusive Business: Our Bureau, Mumbai Wednesday, July 29, 2026, 16:30 Hrs [IST] Parexel, a leading global clinical development pa ...
Pharmabiz

AOTI gains transformational milestone; expands the US addressable market and growth potential for its TWO2 therapy

AOTI gains transformational milestone; expands the US addressable market and growth potential for its TWO2 therapy: Oceanside Wednesday, July 29, 2026, 14:00 Hrs [IST] AOTI, Inc, ...
Pharmabiz

Galmed Pharma announces breakthrough development of dispersible film delivery, brain penetrating formulation of its SCD1 inhibitor Aramchol for Parkinson's disease

Galmed Pharma announces breakthrough development of dispersible film delivery, brain penetrating formulation of its SCD1 inhibitor Aramchol for Parkinson's disease: Ramat-Gan, Isr ...
Pharmabiz

Pace Life Sciences announces compliant US FDA inspection of operations in Research Triangle Park facility

Pace Life Sciences announces compliant US FDA inspection of operations in Research Triangle Park facility: Raleigh, North Carolina Wednesday, July 29, 2026, 17:00 Hrs [IST] Pace L ...
Pharmabiz

RPG Life Sciences Q1 revenue rises 15.8 per cent

Our Bureau, Mumbai Wednesday, July 29, 2026, 14:40 Hrs [IST] RPG Life Sciences Limited announced its financial results for the qu ...
Pharmabiz

Healthcare and pharmaceuticals enter the next phase of growth with AI-led transformation: Deloitte India

Healthcare and pharmaceuticals enter the next phase of growth with AI-led transformation: Deloitte India: Our Bureau, Bengaluru Wednesday, July 29, 2026, 14:15 Hrs [IST] India’s ...
Pharmabiz

Gland Pharma receives approval for sugammadex injection

Gland Pharma Limited, a generic injectable & ophthalmic focused pharmaceutical company, has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug ...